These Are Apex Capital Management’s Top Biotech Stock Picks
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion in assets under management...
Posts Tagged ‘Isis Pharmaceuticals Inc (ISIS)’
ISIS Pharmaceuticals, Inc. (ISIS) Has Strong Momentum With Massive Drug Pipeline: Cramer
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) appears to be trending in the right direction again after a sharp decline earlier this year.
Four Reasons to Buy This Biotechnology Stock
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best performing stocks in the ...
Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech
With all of the heat generated by this biotech and its stock, it pays to pay attention to what Celgene Corporation (NASDAQ:CELG) says.
GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Biogen Idec Inc (BIIB), ISIS Pharmaceuticals, Inc. (ISIS), Alnylam Pharmaceuticals, Inc. (ALNY): A Ringing Endorsement of a Technology Years in the Making
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I know it's like comparing apples and oranges, but humor me for a moment.
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN), Amgen, Inc. (AMGN): Invest in the Next Biotech Frontier
The last several months have been remarkably exciting in the biotech space.
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years.
Biogen Idec Inc (BIIB): Why ISIS Pharmaceuticals, Inc. (ISIS) Shares Leapt Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
The Medicines Company (MDCO), United Therapeutics Corporation (UTHR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age.
Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
Sarepta Therapeutics Inc (SRPT), ISIS Pharmaceuticals, Inc. (ISIS): Is Questcor Pharmaceuticals Inc (QCOR) Still Undervalued?
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to lose more than half of its...
Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO
The Motley Fool's readers have spoken, and I have heeded their cries.
Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
As human beings it can sometimes be difficult for us to see the good in a bad situation.
ISIS Pharmaceuticals, Inc. (ISIS), Aegerion Pharmaceuticals, Inc. (AEGR): Two Drugs Competing for an One-In-A-Million Disease
Both ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) and Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities
The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases.
Aegerion Pharmaceuticals, Inc. (AEGR), Mosaic Co (MOS), Staples, Inc. (SPLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Alnylam Pharmaceuticals, Inc. (ALNY), ISIS Pharmaceuticals, Inc. (ISIS), Merck & Co., Inc. (MRK): RNAi Companies to Consider
RNAi and RNA companies had a terrible time when they were abandoned by big pharmaceutical companies.
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.
Antares Pharma Inc (ATRS), ISIS Pharmaceuticals, Inc. (ISIS), Ligand Pharmaceuticals Inc. (LGND): 3 Pharma Stocks You Need to Watch for the Rest of 2013
It's hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks -- at least so far.
ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense
In the last couple of years, the biotechnology industry has been on a roll.
VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Research In Motion Ltd (BBRY) & Other Upgrades You Should Consider
With the markets under pressure, we are beginning to see more downgrades and fewer upgrades.
Aegerion Pharmaceuticals, Inc. (AEGR), MannKind Corporation (MNKD): 3 Biotech Companies You Should Have Bought This Year
If you'd owned these three biotech companies at the beginning of the year, you're sitting on around a triple compared to a relatively smaller-but-still-impressive 34% increase...
Why Aegerion Pharmaceuticals, Inc. (AEGR) Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Regeneron Pharmaceuticals Inc (REGN), Questcor Pharmaceuticals Inc (QCOR), Aegerion Pharmaceuticals, Inc. (AEGR): Three Booming Biotech Companies
Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these three biotech companies.
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Two Orphan Drugmakers With Upcoming Catalysts
Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical Corp.
Apple Inc. (AAPL) & Ten Ways NASCAR Can Teach Us How to Invest Better: Part 2
Yesterday we looked at the first part of my attempt to parallel the similarities between one of America's most-watched sports, auto racing (i.e., NASCAR), and investing.
Pharmacyclics, Inc. (PCYC), Keryx Biopharmaceuticals (KERX): These Cutting-Edge Science Stocks Are Soaring
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Sanofi SA (ADR) (SNY), Aegerion Pharmaceuticals, Inc. (AEGR): ISIS Pharmaceuticals, Inc. (ISIS), Big Pharma’s Little Friend
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc.
Should AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY) Get Married?
It's been quite a while since we had a big wedding in the pharma world.
Why Cisco Systems, Inc. (CSCO)’s Sinking the Dow This Morning: Oracle Corporation (ORCL)
The stock market is stuck in a waiting game as investors wait for a resolution to the Cypriot banking crisis. In the meantime, the U.S.
Three Stocks For The Long Haul: NetEase, Inc (ADR) (NTES), Tenet Healthcare Corp (THC), ISIS Pharmaceuticals, Inc (ISIS)
I have reviewed over 80 stocks as investment opportunities.
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs -- medications meant for small patient populations with rare, dangerous diseases -- can be a rewarding business for biotech firms that strike gold.
Will ISIS Pharmaceuticals, Inc. (ISIS) Right Pfizer Inc. (PFE)’s Wrong?
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) started the year strong with a Food and Drug Administration approval for genetic high cholesterol drug Kynamro.
Sanofi SA (SNY) & ISIS Pharmaceuticals, Inc. (ISIS) Out-Limbo Aegerion Pharmaceuticals, Inc. (AEGR) in HoFH
I was admittedly never very good when it came to limbo because I'm not very flexible and I'm all legs. Sanofi SA (ADR) (NYSE:SNY) and ISIS Pharmaceuticals, Inc.
